Back to Search
Start Over
High-dose chemotherapy with busulfan and cyclophosphamide and autologous stem cell rescue in patients with Hodgkin lymphoma.
- Source :
-
Leukemia & lymphoma [Leuk Lymphoma] 2011 Jul; Vol. 52 (7), pp. 1363-6. Date of Electronic Publication: 2011 May 25. - Publication Year :
- 2011
- Subjects :
- Busulfan administration & dosage
Busulfan adverse effects
Cyclophosphamide administration & dosage
Cyclophosphamide adverse effects
Hodgkin Disease drug therapy
Hodgkin Disease mortality
Humans
Myeloablative Agonists administration & dosage
Myeloablative Agonists adverse effects
Neoplasms, Second Primary
Survival Analysis
Transplantation, Autologous
Treatment Outcome
Busulfan therapeutic use
Cyclophosphamide therapeutic use
Hematopoietic Stem Cell Transplantation adverse effects
Hodgkin Disease therapy
Myeloablative Agonists therapeutic use
Transplantation Conditioning
Subjects
Details
- Language :
- English
- ISSN :
- 1029-2403
- Volume :
- 52
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Leukemia & lymphoma
- Publication Type :
- Editorial & Opinion
- Accession number :
- 21612379
- Full Text :
- https://doi.org/10.3109/10428194.2011.572324